• Edwards Lifesciences average return on tangible equity for 2023 was 31.05, a 9.87% increase from 2022.
• Edwards Lifesciences average return on tangible equity for 2022 was 34.45, a 13.27% decline from 2021.
• Edwards Lifesciences average return on tangible equity for 2021 was 39.72, a 12.3% decline from 2020.

Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.